Oncology News, Insights, Stories by OncoDaily

Best of ESMO India 2025
2025-12-13 - 2025-12-14 | The St. Regis Mumbai, 462 Senapati Bapat Marg, Lower Parel, Mumbai, Maharashtra, 400013, India
The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai, scheduled for December 13–14, 2025.
This conference, hosted by the Global Healthcare Academy (GHA), is a major platform for disseminating the most recent, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress.
Designed for a multidisciplinary audience including medical, surgical, and radiation oncologists, the event will feature focus sessions guided by an extensive advisory, core, and scientific committee comprising leading Indian oncologists, and will be held at The St. Regis Mumbai.
Register.

ESMO Preceptorship on Prostate Cancer 2025: Lugano
2025-12-16 - 2025-12-17 | Lugano, Switzerland
The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management, from diagnosis to treatment, according to current standards of care.
Organized by the European Society for Medical Oncology (ESMO), the event is scheduled to take place on December 16–17, 2025, in Lugano, Switzerland. The preceptorship is designed primarily for medical and clinical oncologists, especially young oncologists, and has been accredited for 9 ESMO-MORA category 1 points.

1st National Oncology Nursing Conference
2025-12-16 - 2025-12-18 | Babcock University Ilishan Remo, VPQ9+VPP, Ilishan-Remo, Ilishan-Remo, Ogun State, 121103, Nigeria
The Oncology Nursing Society of Nigeria (ONSN) is hosting its 1st National Oncology Nursing Conference titled “Oncology Nursing in the Spotlight: Celebrating Excellence and Inspiring Growth.”
The conference is scheduled for December 16–18, 2025, at Babcock University in Ilishan Remo, Ogun State, Nigeria.
This landmark event aims to bring together over 500 local and international nursing leaders, researchers, clinicians, and policymakers to strengthen cancer care delivery and workforce development across Nigeria and Africa. Attendees will gain actionable strategies for advancing oncology nursing practice, policy, and research.

Digestive Oncology Autumn Symposium, Edition 2025
2025-12-16 13:00 - 17:40 (America/Halifax) | Salons De Romree, Beiaardlaan 31, Grimbergen, Flemish Brabant, 1850, Belgium
The Digestive Oncology Autumn Symposium, Edition 2025, is scheduled for the afternoon of Tuesday, December 16, 2025, at Salons De Romree in Grimbergen, Belgium. The event will begin with a lunch from 1:00 PM to 2:00 PM, followed by the scientific presentations from 2:00 PM to 5:40 PM. This annual congress is presented by The Merck Medical Team and is a premier gathering for professionals interested in Antibody-Drug Conjugates (ADCs).
The symposium features a distinguished faculty of speakers and moderators, including Professor Sabine Tejpar (UZ Leuven), Dr. Gertjan Rasschaert (UZ Leuven/ZAS Antwerpen), and Dr. Jochen Decaestecker (AZ Delta). They will be joined by international experts like Dr. Elizabeth Smyth (Oxford University, UK) and Dr. Pia Österlund (Karolinska University Hospital, Sweden). Attendees from over five countries will discuss the latest insights in digestive oncology.
Register.

The State of AI in Precision Oncology 2025
2025-12-16 20:00 - 2025-12-17 00:00
The State of AI in Precision Oncology 2025 is the third annual, free virtual summit hosted by the journal AI in Precision Oncology, aiming to assess the current evolution of medicine driven by Artificial Intelligence, specifically within the field of oncology.
Scheduled for Tuesday, Dec 16, 2025 at 8:00 PM – Wednesday, Dec 17, 2025 at 12:00 AM (+04), the event features keynote interviews, presentations, and fireside chats with renowned experts like Amy Abernethy (former FDA executive), Isaac Kohane (Founding Editor of NEJM AI), and Connie Lehman (on AI in breast cancer screening).
The summit documents how clinicians are increasingly deploying AI applications and strategies to personalize treatments and transform their practice, covering topics from blood-based cancer screening to the state of AI in community hospitals and a look ahead to “AI in Oncology 2030.”

EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC
2025-12-17
The EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC is scheduled for December 17, 2025, at 18:00 CET. This free, open-to-all online event will feature experts from medical oncology, radiation oncology, and thoracic surgery who will explore and discuss the status of current as well as upcoming clinical trials focused on the treatment of Stage III non-small cell lung cancer.
Register.

SITC Webinar on Bispecifics and T Cell Engagers: Practical Strategies for Recognizing and Managing Toxicities
2025-12-17 13:00 - 14:15
The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual, multi-stakeholder event scheduled for December 17, 2025, from 1:00 p.m. to 2:15 p.m. ET. The webinar will feature expert faculty, including Sid Devarakonda, MD, and Megan May, PharmD, to provide clinical insights into the use of bispecifics and T cell engagers and the necessary management of their associated toxicity.
The primary focus is on identifying and employing best practices for treating immune-related adverse events (irAEs), particularly Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS), with the goal of improving patient outcomes through multidisciplinary and collaborative approaches.
Register.

Going Full TILt: Challenges, Successes, and Coordination with Administering TIL Therapy
2025-12-17 14:00 - 15:00
“Going Full TILt: challenges, successes, and coordination with administering TIL therapy” is an upcoming “Rx-cited: Clinical Conundrums” roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task Force, scheduled for Wednesday, December 17, 2025, from 2:00–3:00 PM CST.
The session is designed to be an informal Q&A discussion focusing on the challenges, key points, and future directions associated with offering Tumor Infiltrating Lymphocyte (TIL) therapy, providing a space for both members and non-members working in transplantation and cellular therapy to connect and share insights on these latest advancements.
Register.

ASCO Gastrointestinal Cancers Symposium 2026
2026-01-08 08:00 - 2026-01-10 17:00 | Moscone West, 800 Howard Street, San Francisco, United States
The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online.
This annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment, research, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions, the symposium offers a platform for clinicians, researchers, and industry experts to exchange insights and shape the future of gastrointestinal oncology.
With a focus on innovative science and solution-oriented strategies, the symposium covers a broad range of GI cancers including colorectal, pancreatic, liver, and esophageal cancers. Attendees can expect expert-led sessions, abstract presentations, and practical discussions on integrating new research into clinical practice.

2026 Highlights of ASH in North America
2026-01-09 - 2026-01-10
The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and novel research presented at the latest ASH Annual Meeting. The program is designed to allow hematology leaders and experts to connect in person, learn how to apply the latest research to their areas of expertise, and gain insights into local and regional standards of care. In 2026, the two-day program will be offered on four separate dates and locations:

Chicago, Illinois | January 9-10, 2026
New York, New York | January 9-10, 2026
Washington, D.C. | January 16-17, 2026
Seattle, Washington | January 30-31, 2026

Register.

ANCO’s Medicare Regulations Update 2026
2026-01-14 12:30 - 13:30
The ANCO’s Medicare Regulations Update 2026 webinar on January 14, 2026, will provide a comprehensive overview of the latest Medicare changes affecting oncology services.
Bobbi Buell, MBA, will cover updates to the Physician Fee Schedule, coding and billing, evaluation and management, and incentive programs, offering essential insights for clinicians and practice teams.
Register here.

MASCC Webinar: ADCs and Mucositis: From Mechanism to Care
2026-01-15 20:00 | https://oncodaily.com/event/mascc-418960
The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15, 2026, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs), with a focus on the recognition, prevention, and management of ADC-induced oral mucositis.
Expert speakers, including Prof. Paolo Bossi, Prof. Florian Scotté, Dr. Barbara Pistilli, Dr. Emmanuelle Vigarios, and Dr. Helen Bulbeck, will share clinical insights, strategies for supportive care, and the patient perspective on mucositis. This educational session is supported by an unrestricted grant from Daiichi Sankyo Europe.
Register here.

ESMO Preceptorship on Breast Cancer 2026: Milan
2026-01-16 - 2026-01-17 | Milan, Italy
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting.
The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is accredited with ESMO-MORA category 1 points, and the application deadline for attendance is November 25, 2025.
Apply.

Cancer Immunotherapy Winter School 2026
2026-01-16 - 2026-01-18 | The Westin Copley Place, Boston, 10 Huntington Avenue, Boston, MA, 02116, United States
The Cancer Immunotherapy Winter School, hosted by the Society for Immunotherapy of Cancer (SITC), is a hybrid program taking place in Boston and virtually from February 16–18, 2026, with the in-person meeting held at The Westin Copley Place, Boston.
The school is tailored for early-to-mid career scientists and clinicians who are new to the field, providing intensive education from leading experts. The curriculum offers separate clinical and research tracks that cover the fundamental principles of tumor immunology, cancer immunotherapy, and developing areas such as biomarker technology, clinical trial design, and considerations for combination therapies. Travel awards are available, and Continuing Education Credits are planned for the program.
Register.

22nd Oncology Updates: Advanced and Controversies Conference
2026-01-16 07:00 - 2026-01-19 12:00 | Steamboat Grand, 2300 Mt Werner Cir, Steamboat Springs, CO, 80487, United States
The 22nd Oncology Updates: Advanced and Controversies Conference, presented by The University of Texas MD Anderson Cancer Center, is an interactive, multidisciplinary forum held from Friday, January 16 to Monday, January 19, 2026, at the Steamboat Grand Hotel in Steamboat Springs, Colorado.
The conference is designed to address the rapidly evolving complexities of solid tumor management, convening leading experts in surgical, medical, and radiation oncology, among other specialties, to explore current challenges, novel therapies, and clinical controversies through evidence-driven and case-based discussions.
Register.

The 2nd Annual Cleveland Clinic Cancer Conference
2026-01-16 08:00 - 2026-01-18 17:00 | Margaritaville Hollywood Beach Resort, 1111 N Ocean Dr, Hollywood, Los Angeles, United States
The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18, 2026, in Hollywood, Florida.
This premier event brings together a diverse range of oncology professionals including medical oncologists, hematologists, radiation oncologists, and other healthcare providers to explore the latest developments in cancer diagnosis, treatment, and supportive care. Through a combination of evidence-based lectures and case-based discussions, attendees will gain valuable insights into managing common and complex cancer cases across all disease stages.
This conference emphasizes a multidisciplinary approach to cancer care, with focused sessions on disease-specific updates, innovative technologies, and integrative care strategies. Participants can expect to learn about cutting-edge research, evolving therapeutic options, and best practices in clinical decision-making. The event also highlights the importance of supportive and non-pharmacologic care, addressing the broader needs of patients beyond conventional treatments.
Registration is Open for The Event.
You Can Find More Posts Featuring Cleveland Clinic.

Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy
2026-01-20 - 2026-01-21
The European Association for Cancer Research (EACR) conference, “Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy,” is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic signaling pathways.
Accumulating evidence suggests that excessive stimulation can lead to cancer cell death by causing a further activation of cellular stress responses. The meeting, chaired by Rene Bernards, aims to give the audience a fundamentally different perspective on treating advanced cancers where conventional inhibition strategies have failed, by focusing on drugs that activate oncogenic signaling and the resulting vulnerabilities of cancer cells.

Better Breathing Week 2026
2026-01-20 - 2026-01-24 | Hyatt Regency Toronto, 370 King Street West, PO Box 137, Toronto, Ontario (ON), M5V 1J9, Canada
The Better Breathing Week 2026 is the 43rd annual accredited lung health conference presented by the Lung Health Foundation, scheduled to take place from January 20–24, 2026, both in-person at the Hyatt Regency in Toronto, Canada, and virtually. As one of Canada’s leading respiratory medical conferences, it brings together healthcare professionals, researchers, policymakers, and patient advocates to explore the latest innovations and drive meaningful change in respiratory care.
The program focuses on breaking down silos and uniting disciplines, with highlights including dedicated sessions for primary care providers on topics like spirometry access, vaccine uptake, and severe asthma identification. The conference is accredited for Continuing Professional Development (CPD), offering physicians up to 27.5 Mainpro+ credits for Family Medicine Specialists and 27.5 hours (Section 1) for Royal College Specialists.
Read more about this event.

Highlights from ABC 8 - International Consensus Guidelines for Advanced Breast Cancer management
2026-01-22
The Sharing Progress in Cancer Care (SPCC), in collaboration with the ABC Global Alliance, is hosting a live webinar titled “Highlights from ABC 8 – International Consensus Guidelines for Advanced Breast Cancer Management“ on Thursday, January 22, 2026, at 18:00 CET.
This session is specifically designed to provide essential updates for those unable to attend the ABC 8 conference in person, covering critical advancements in the management of ER+/HER2-negative, HER2-positive, and triple-negative advanced breast cancer.
Featuring renowned experts such as Fatima Cardoso, Alexandru Eniu, and Shani Paluch-Shimon, the webinar aims to translate the latest international consensus guidelines into clinical practice through expert discussion and an interactive Q&A session.

You can also read more posts featuring SPCC and the ABC Global Alliance on OncoDaily.

Cardiotoxicity in Pediatric Oncology or Cardiomyopathy in Childhood Cancer
2026-01-22
Cardiotoxicity in Pediatric Oncology or Cardiomyopathy in Childhood Cancer is an expert-led webinar hosted by the International Society of Paediatric Oncology (SIOP) on January 22, 2026, at 14:00 UTC.
This session focuses on identifying, monitoring, and managing treatment-related heart damage to improve long-term outcomes for pediatric cancer survivors. Part of the SIOP Global Health Supportive Care series, it provides a critical platform for clinicians to discuss evidence-based strategies for mitigating cardiac risks in young patients.
Register.

18th Breast Gynecological International Cancer Conference (BGICC)
2026-01-22 - 2026-01-23 | Hilton Cairo Heliopolis, El-Orouba, Sheraton Al Matar, El Nozha, Cairo, 11361, Egypt
The 18th Breast, Gynecological and Immuno‑oncology International Cancer Conference (BGICC 2026) will take place on 22–23 January 2026 at the Hilton Heliopolis Hotel in Cairo, Egypt.
Recognized as the largest and most prestigious oncology conference in Africa and the Middle East, BGICC 2026 will bring together leading oncology professionals, researchers, and clinicians to discuss the latest advancements in breast cancer, gynecological oncology, and immuno-oncology. The conference will feature high-quality lectures, interactive workshops, and hands-on courses, providing attendees with insights into innovative treatment protocols, emerging therapies, and best practices in patient care, while fostering collaboration and networking with global leaders in the field.

NRG Oncology Winter Meeting 2026
2026-01-22 - 2026-01-24 | Hilton San Francisco Union Square, 333 O'Farrell St, San Francisco, CA 94102,
The NRG Oncology Winter Meeting 2026 will be held from January 22-24, 2026, at Hilton San Francisco Union Square in San Francisco, USA. This semiannual event brings together oncology researchers, clinicians, and professionals to discuss advances in clinical trials, cancer treatment protocols, translational research, and quality of life interventions.
Attendees can expect a range of scientific sessions, protocol development workshops, networking events, and opportunities to engage in collaborative projects aimed at improving patient outcomes in cancer care. The meeting is a key forum for launching new studies, reviewing current data, and fostering innovation within the NRG Oncology research community.

ANCO's Clinical Cancer Update 2026
2026-01-23 - 2026-01-25 | Everline Resort & Spa Lake Tahoe, 400 Resort Road, Olympic Valley, CA, 96146, United States
ANCO’s Clinical Cancer Update 2026, taking place January 23–25, 2026, at the Everline Resort and Spa, will highlight the latest breakthroughs in cancer treatment across multiple specialties, including breast, gastrointestinal, genitourinary, lung, hematologic, and CNS cancers.
The three-day meeting offers cutting-edge clinical content, opportunities for professional networking, and insights into translational science, chemotherapy, radiation, and surgical protocols, providing up to 12.25 AMA PRA Category 1 Credits™ for healthcare providers.
Register here.

The All-Island Forum on Cancer Data 2026
2026-01-26 - 2026-01-27 | Queen’s University Belfast, University Rd, Belfast BT7 1NN, United Kingdom, Belfast, Northern Ireland, BT7 1NN, United Kingdom
The All-Island Forum on Cancer Data, themed “From Data to Impact: Roadmap for Cancer Data,” will be held on 26–27 January 2026 at Queen’s University Belfast. This two-day event will bring together researchers, clinicians, and data experts from across Ireland and Europe to explore the transformative role of data in advancing cancer research, treatment, and care.
Key topics to be addressed include research through data innovation, improving access to clinical trials and medicines, ethical data sharing, and tackling the real-world data skills gap. The forum will also feature the inaugural OHDSI Ireland Node Joint Meeting and Workshop, marking an important step toward building an integrated cancer data ecosystem across the island. Registration details and participation fees have not yet been announced.
You can find more posts featuring Queen’s University Belfast on OncoDaily.

Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics
2026-01-26 - 2026-01-29 | Embassy Suites by Hilton Raleigh Durham Research Triangle, 201 Harrison Oaks Blvd, Cary, NC, 27513, United States
The Keystone Symposia conference titled “Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics“ will take place from January 26–29, 2026, at the Embassy Suites by Hilton Raleigh Durham Research Triangle in Cary, North Carolina, United States.
This meeting, organized by Scientific Organizers including Anwesha Dey, Laura D. Attardi, and Mariam Jamal-Hanjani, is dedicated to exploring the cell-intrinsic mechanisms that drive carcinogenesis and cancer progression, with a distinct focus on understanding how genetic, epigenetic, and metabolic changes within cancer cells create vulnerabilities that can be targeted for therapeutic interventions, thereby inspiring new approaches to cancer treatment.

10th ESO SIOPE Masterclass in Paediatric Oncology
2026-01-26 - 2026-03-15 | Hospital Sant Joan de Deu, Pg. de Sant Joan de Déu, 2, 08950 Esplugues de Llobregat
The 10th ESO SIOPE Masterclass in Paediatric Oncology is scheduled from October 1, 2025, to March 16, 2026, with the first block delivered online and the second block held in Barcelona, Spain. It offers state-of-the-art plenary lectures, interactive workshops, tumor board simulations, and case-based discussions with expert feedback.
The program is aimed at enhancing clinical management skills in childhood tumors, leukemia, and lymphoma, applying the latest research findings to practice. Attendance is by application only, with successful applicants granted free registration. The course also provides 30 ESCO credits for continuing medical education.

ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026
2026-01-28
The ESMO Guidelines: Real World Cases – Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28, 2026, at 18:30 CET (Central European Time).
Register.

Foundations in Immunotherapy in the Oncology Population: Strategies for Clinical Application and Patient Management
2026-01-28 08:00 - 16:45
The Memorial Sloan Kettering Cancer Center (MSKCC) is hosting a one-day live virtual CME program, “Foundations in Immunotherapy in the Oncology Population: Strategies for Clinical Application and Patient Management,” on Wednesday, January 28, 2026, from 8:00 AM to 4:45 PM ET.
This comprehensive course is designed for physicians, advanced practice providers (APPs), and allied health professionals, offering a review of foundational concepts and emerging advances in cancer immunotherapy, including immune checkpoint blockade, CAR T-cell therapy, TIL, and BiTE therapies.
Register.

Joint Meeting of ICIS and ORMIS: From Oman to the World: Defining New Horizons in Medical Imaging
2026-01-30 - 2026-01-31 | Grand Hyatt Muscat, Way no. 3032, As Saruj St, Muscat, Muscat Governorate, 133, Oman
The Joint Meeting of ICIS and ORMIS: From Oman to the World: Defining New Horizons in Medical Imaging is an in-person satellite event scheduled for January 30–31, 2026, starting at 7:30 AM, taking place at the Grand Hyatt in Muscat, Sultanate of Oman.
This collaborative meeting between the International Cancer Imaging Society (ICIS) and the Oman Radiology and Molecular Imaging Society (ORMIS) aims to foster the exchange of knowledge, showcase the latest trends in cancer imaging from head to toe, and promote best practices that will enhance patient care and outcomes.
The two-day conference will feature interactive, case-based learning, focusing on cutting-edge technologies and practical clinical applications, offering a unique platform to strengthen global and regional networks in medical imaging.
Register.

2026 AAOM Winter Meeting
2026-01-31
The 2026 American Academy of Oral Medicine (AAOM) Winter Meeting, themed “Oral-Systemic Synergy: Collaborative Perspectives in Oral Health,” will be held on Saturday, January 31, 2026. This event will be conducted virtually (online).
The meeting is eligible for 5 CERP Continuing Education (CE) credits and is designed to deliver essential updates and contemporary trends in the field of oral medicine. The program includes a specific collaborative session on “Oncology, Immunotherapy, and Oral Complications,” reflecting the meeting’s focus on the interdisciplinary approach to oral health and systemic diseases.
Register.
